Conclusion: Heterozygous Arg/Gly, homozygous Gly/Gly and Gly Allele were found to be significantly associated with
nocturnal asthma.
Therefore, in clinical work, it is difficult to differentiate OSA from
nocturnal asthma just based on patient's complaints.
From this, they concluded that even small amounts of melatonin could cause problematic inflammation for people with
nocturnal asthma.
A severe case of asthma was defined as a patient with four of the following, in any combination: i) daily shortness of breath, ii) more than 3 visits to the emergency room due to asthma attacks in the 12 months prior to the interview; iii) more than 2 hospitalizations due to asthma attacks in the 12 months prior to the interview, iv) continuous symptoms between asthma attacks, v) marked limitation of physical activity, vi)
nocturnal asthma symptoms more than 3 times a week, vii) poor attendance in school or work, and viii) emergency room time of more than 3 hours in a single visit.
If you suffer from arthritis, you're " more prone at night because Sleep-stealer: Trouble breathing Cause:
Nocturnal asthma, heart condition If you are asthmatic, sleeping can make you feel worse - lying down means mucus can build in the airways, creating pressure on the lungs.
Nocturnal asthma in school children of south Punjab Pakistan.
The more well-known asthma phenotypes include allergic asthma, non-allergic asthma,
nocturnal asthma and aspirin sensitivity asthma.
Some of the features that have been described include resistance or susceptibility to down-regulation,
nocturnal asthma and augmentation of the beta-agonist response.
Nocturnal asthma symptoms that caused awakening were more likely to cause a change in family plans, compared with those symptoms that didn't (38% vs.
So the goal becomes preventing all
nocturnal asthma episodes.
Salmeterol is commonly used in pediatric asthma patients to prevent symptoms of
nocturnal asthma and prevent exercise-induced asthma.
1] Clinicians should anticipate future studies comparing long-acting inhaled [Beta]-agonists in patients with
nocturnal asthma symptoms to determine which agents are most efficacious, cost-effective, and have the fewest adverse effects.
